| Product Code: ETC7540017 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Clinical Oncology NGS Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Clinical Oncology NGS Market Revenues & Volume, 2021 & 2031F |
3.3 India Clinical Oncology NGS Market - Industry Life Cycle |
3.4 India Clinical Oncology NGS Market - Porter's Five Forces |
3.5 India Clinical Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 India Clinical Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.7 India Clinical Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 India Clinical Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 India Clinical Oncology NGS Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in India |
4.2.2 Growing demand for personalized medicine in oncology |
4.2.3 Technological advancements in next-generation sequencing (NGS) technologies |
4.2.4 Government initiatives to improve cancer care and research in India |
4.3 Market Restraints |
4.3.1 High cost associated with NGS testing |
4.3.2 Limited awareness and access to advanced oncology diagnostics in certain regions of India |
4.3.3 Regulatory challenges and lack of standardized guidelines for NGS testing in oncology |
5 India Clinical Oncology NGS Market Trends |
6 India Clinical Oncology NGS Market, By Types |
6.1 India Clinical Oncology NGS Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 India Clinical Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 India Clinical Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 India Clinical Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 India Clinical Oncology NGS Market Revenues & Volume, By Targeted Sequencing & Resequencing Centrifuges, 2021- 2031F |
6.2 India Clinical Oncology NGS Market, By Workflow |
6.2.1 Overview and Analysis |
6.2.2 India Clinical Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.2.3 India Clinical Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.2.4 India Clinical Oncology NGS Market Revenues & Volume, By Data Analysis, 2021- 2031F |
6.3 India Clinical Oncology NGS Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 India Clinical Oncology NGS Market Revenues & Volume, By Screening, 2021- 2031F |
6.3.3 India Clinical Oncology NGS Market Revenues & Volume, By Companion Diagnostics, 2021- 2031F |
6.3.4 India Clinical Oncology NGS Market Revenues & Volume, By Other Diagnostics, 2021- 2031F |
6.4 India Clinical Oncology NGS Market, By End-use |
6.4.1 Overview and Analysis |
6.4.2 India Clinical Oncology NGS Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 India Clinical Oncology NGS Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 India Clinical Oncology NGS Market Revenues & Volume, By Laboratories, 2021- 2031F |
7 India Clinical Oncology NGS Market Import-Export Trade Statistics |
7.1 India Clinical Oncology NGS Market Export to Major Countries |
7.2 India Clinical Oncology NGS Market Imports from Major Countries |
8 India Clinical Oncology NGS Market Key Performance Indicators |
8.1 Adoption rate of NGS technologies in clinical oncology practices in India |
8.2 Number of oncology research studies utilizing NGS technology |
8.3 Rate of integration of NGS results in treatment decision-making for cancer patients in India |
9 India Clinical Oncology NGS Market - Opportunity Assessment |
9.1 India Clinical Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 India Clinical Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.3 India Clinical Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 India Clinical Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 India Clinical Oncology NGS Market - Competitive Landscape |
10.1 India Clinical Oncology NGS Market Revenue Share, By Companies, 2024 |
10.2 India Clinical Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here